tiprankstipranks
Careteq Reports Strong Q2 FY25 with Successful Integration and Revenue Growth
Company Announcements

Careteq Reports Strong Q2 FY25 with Successful Integration and Revenue Growth

Story Highlights

Invest with Confidence:

An update from Careteq Ltd. ( (AU:CTQ) ) is now available.

Careteq Limited reported a successful quarter with the integration of Embedded Health Solutions (EHS) and HMR Referrals progressing well, enhancing operational efficiencies and expanding service offerings. The company achieved a 14% increase in unaudited revenue for the first half of FY25 and is on track with the rollout of its new integrated operating platform. The integration aims to provide a seamless service offering, improve patient outcomes, and deliver cost savings. Partnerships with key home care providers and the Pharmaceutical Society of Australia are strengthening its market presence, while financials show improved cash flow and disciplined cost management.

More about Careteq Ltd.

Careteq Limited is a clinical healthtech company specializing in innovative medication management and clinical governance solutions. It focuses on providing integrated solutions for aged care, home care, and disability sectors through its medication management platforms.

YTD Price Performance: 50.0%

Average Trading Volume: 299,173

Technical Sentiment Consensus Rating: Sell

For detailed information about CTQ stock, go to TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App